We wrote earlier about exciting new data from clinical trials of leukemia patients treated with experimental T-cell immunotherapy. The data was presented today in a press conference by LLS-funded researchers from University of Pennsylvania and Children’s Hospital of Philadelphia at the American Society of Hematology meeting in New Orleans. LLS Chief Scientific Officer Lee Greenberger, Ph.D., is quoted today in an Associated Press and Bloomberg News articles about these remarkable advances. You can read the articles here and here. LLS has invested more than $15 million in this work, with another $6 million committed through 2017.
Photo:Emily Whitehead, 8, T-cell immunotheray patient (photo credit courtesy of AP Photo/Children's Hospital of Philadelphia, Ed Cunicelli)